Overview


According to FutureWise analysis, the type streptococcus rapid test market in 2025 is US$220.3 million, and is expected to reach over US$416.05 million by 2033 at a CAGR of 8.27%. The increasing prevalence of streptococcal infections and the growing demand for point-of-care diagnostics are significant drivers of market growth. Additionally, advancements in rapid antigen detection technologies and their wider adoption in hospitals, clinics, and diagnostic laboratories are contributing to this expansion. Increased awareness of the importance of early diagnosis and treatment efficiency is also boosting the global demand for rapid testing for streptococcal infections.The market for A type Streptococcus rapid tests was valued at $34 million in 2023 and is expected to exceed $60 million by 2031, growing at a CAGR of 8.6%. This growth is driven by the rising incidence of streptococcal infections, especially in children and the elderly, as well as the demand for quick, accurate point-of-care diagnostics. Improved test sensitivity and increased awareness of early detection also contribute to the adoption of these tests.

Type A strep is a type of bacteria known as streptococcus pharyngitis. Type A streptococcus is common bacteria that causes various infections, like strep throat, scarlet fever, and invasive disease. Strep throat is an contamination that affects the throat and tonsils area. The infection is spread from one individual to other through coughing or sneezing. While one can get strep throat at any age, it's mostly common in children 5 to 15. Strep throat are easily treated with antibiotics medication, but if left untreated, strep throat can lead to severe complications. These complication include rheumatic fever, a disease that effects the heart and joints, and glomerulonephritis, a type of kidney disease.

From 2024 to 2025, the Type A Streptococcus Rapid Test Market saw significant advancements. Roche received FDA clearance for its cobas Strep A test, while Abbott launched the ID NOW Strep A 2, providing results in six minutes without culture confirmation. QuidelOrtho expanded its Sofia Strep A FIA platform, and VivaChek gained IVDR certification in Europe for self-testing kits, indicating a shift toward at-home diagnostics. Innovative methods like saliva-based sampling and expanded distribution through pharmacies are enhancing convenience and access, reflecting a strong trend toward rapid molecular diagnostics and regulatory acceptance of self-testing.

The rapid antigen detection test (RADT) has largely replaced microbiological culturing as the initial test for detecting, throat swab culture, or both in patients with pharyngitis, except for those with overt viral symptoms in the USA. A throat culture in children should approve negative RADT results. Positive RADTs do not require backup culture tests due to their high specificity. Compared with the throat swab culture method, commercially available RADTs have sensitivity and specificity of 77%–98.9% and 62%–100%, respectively. The differences between various RADTs could be attributed to the skill level of individuals performing the tests, somewhat subjective interpretation of RADT endpoint, different commercial kits, and the quality of culture. Given the importance of RADT in diagnosing acute pharyngitis, a more accurate performance evaluation of RADTs is required.

FutureWise Market Research has published a report that provides an insightful a type streptococcus rapid test market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, a type streptococcus rapid test market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • AccuBioTech
  • Alere
  • Concile GmbH
  • CorisBioConcept
  • EKF Diagnostics
  • ELITech Group
  • LifeSign PBM
  • Hologic
  • Quidel

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in the A-Type Streptococcus Rapid Test Market: 

Quidel Corporation

In 2023, a next-generation rapid diagnostic kit was launched, featuring enhanced sensitivity for detecting the Group A Strep antigen. This innovation aims to enhance diagnostic accuracy in point-of-care settings.

EKF Diagnostics

The QuStick™ Strep A rapid test kit is a dip-stick immunoassay that detects Group A Streptococcus antigens from throat swabs in just 5 minutes. With an enhanced sensitivity of ~97%, it remains effective at low bacterial counts and is CLIA-waived, allowing for room-temperature storage and a 20-month shelf life.

AccuBioTech

A Rapid Test Cassette is a chromatographic immunoassay designed for the qualitative detection of Group A Streptococcus antigen from throat swabs. Although this product is marketed globally, specific recent enhancements or regional approvals have not been publicly disclosed as of early 2025.

By Product Type

  • Colorimetric Method
  • Immune Chromatography

By Application

  • Hospitals
  • Family
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. North America has been experiencing a favourable rise for the A type streptococcus rapid test market during the anticipated period due to recent technological advancements and the existence of a number of unique medication molecules to improve the treatment technique. North America has a well-established healthcare infrastructure with advanced diagnostic facilities and a high level of awareness about the importance of early diagnosis and treatment of infectious diseases, including streptococcal infections. This has led to increased adoption of rapid diagnostic tests for streptococcal infections in the region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the A Type Streptococcus Rapid Test market By Product Type, By Application and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate the competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   A Type Streptococcus Rapid Test Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of A Type Streptococcus Rapid Test Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   A Type Streptococcus Rapid Test Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global A Type Streptococcus Rapid Test Market, By Product Type Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Colorimetric Method
        2. Immune Chromatography

  • 8.   Global A Type Streptococcus Rapid Test Market, By Application Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Hospitals
        2. Family
        3. Others

  • 9.   North America A Type Streptococcus Rapid Test Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2025-2033

  • 10.   Latin America A Type Streptococcus Rapid Test Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2025-2033

  • 11.   Europe A Type Streptococcus Rapid Test Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2025-2033

  • 12.   Asia Pacific A Type Streptococcus Rapid Test Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2025-2033

  • 13.   Middle East and Africa Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2025-2033

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. AccuBioTech
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Alere
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Concile GmbH
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Coris BioConcept
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. EKF Diagnostics
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. ELITech Group
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. LifeSign PBM
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Hologic
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Quidel
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client

FAQ


The A-Type Streptococcus Rapid Test is a diagnostic tool designed to quickly detect Streptococcus pyogenes (Group A Strep), the bacteria responsible for illnesses like strep throat, scarlet fever, and other infections. Results are usually available within 5 to 15 minutes, making it suitable for point-of-care testing.

Key growth drivers include the increasing incidence of strep throat in both children and adults, a rising demand for rapid and accurate point-of-care diagnostics, advancements in molecular and antigen-based testing technologies, and a growing global adoption of self-testing kits.

Challenges include false negatives in traditional antigen tests, high costs for molecular platforms, regulatory obstacles in some regions, and the need for wider distribution in developing economies.

Related Market

Veterinary Rapid Test Market

Read More

Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

Read More
Partner

Our Clients